trial · primary record
Azacitidine
Acute Myeloid Leukemia
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 28 |
| Primary completion | 2029-12-01 |
| Primary endpoint | Treatment failure |
| Registry ID | NCT07304011 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:31.543Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07304011
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.